Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
GlaxoSmithKline Australia
Administration route
Intramuscular injection
Vaccine group
Combination vaccines
Description:
Registered for use in people aged ≥1 year.
Hepatitis A and hepatitis B combination vaccine
Each 1.0 mL monodose vial or pre-filled syringe contains:
- 720 ELISA units of inactivated hepatitis A virus (HM175 strain)
- 20 µg recombinant hepatitis B surface antigen protein
- 0.45 mg aluminium as aluminium phosphate and aluminium hydroxide
Also contains traces of:
- formaldehyde
- neomycin
- trometamol
- polysorbate 20
May contain yeast proteins.
For Product Information and Consumer Medicine Information about Twinrix (720/20) visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Allergy advice
May contain yeast proteins.
Page history
Last updated
Last reviewed
Related diseases